Biocurious: Behind Race Oncology’s quest to prevent chemo from being worse than the disease
Cancer survival has dramatically increased, but chemotherapy can lead to lasting organ damage Race plans to launch a cardioprotective study of a repurposed cancer drug, bisantrene Following an innovative options issue, Race is well cashed up to meet its …